Best Practices for Recruiting Underrepresented Groups in Clinical Research 2026
A 2026 study reveals that 75% of U.S. clinical trials still fail to reflect patient diversity, directly threatening treatment safety for underrepresented groups. This isn't a future problem—it's an urgent operational challenge demanding immediate action from every research sponsor and site.